Literature DB >> 10959759

Therapy of respiratory syncytial virus infection.

J P DeVincenzo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10959759     DOI： 10.1097/00006454-200008000-00032

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  6 in total

1.  Viral load drives disease in humans experimentally infected with respiratory syncytial virus.

Authors:  John P DeVincenzo; Tom Wilkinson; Akshay Vaishnaw; Jeff Cehelsky; Rachel Meyers; Saraswathy Nochur; Lisa Harrison; Patricia Meeking; Alex Mann; Elizabeth Moane; John Oxford; Rajat Pareek; Ryves Moore; Ed Walsh; Robert Studholme; Preston Dorsett; Rene Alvarez; Robert Lambkin-Williams
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

Review 2.  Human genetic factors and respiratory syncytial virus disease severity.

Authors:  Isao Miyairi; John P DeVincenzo
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

3.  Use of a highly sensitive strand-specific quantitative PCR to identify abortive replication in the mouse model of respiratory syncytial virus disease.

Authors:  Richard Bannister; Deborah Rodrigues; Edward J Murray; Carl Laxton; Mike Westby; Helen Bright
Journal:  Virol J       Date:  2010-09-22       Impact factor: 4.099

4.  Challenges and opportunities in developing respiratory syncytial virus therapeutics.

Authors:  Eric A F Simões; John P DeVincenzo; Michael Boeckh; Louis Bont; James E Crowe; Paul Griffiths; Frederick G Hayden; Richard L Hodinka; Rosalind L Smyth; Keith Spencer; Steffen Thirstrup; Edward E Walsh; Richard J Whitley
Journal:  J Infect Dis       Date:  2015-03-15       Impact factor: 5.226

5.  The antiviral effects of RSV fusion inhibitor, MDT-637, on clinical isolates, vs its achievable concentrations in the human respiratory tract and comparison to ribavirin.

Authors:  Young-In Kim; Rajat Pareek; Ryan Murphy; Lisa Harrison; Eric Farrell; Robert Cook; John DeVincenzo
Journal:  Influenza Other Respir Viruses       Date:  2017-10-30       Impact factor: 4.380

Review 6.  Innate Type 2 Responses to Respiratory Syncytial Virus Infection.

Authors:  Allison E Norlander; R Stokes Peebles
Journal:  Viruses       Date:  2020-05-08       Impact factor: 5.048
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.